Humacyte (HUMA) Director Jones Keith Anthony Buys 10,000 Shares

What Happened Jones Keith Anthony, a director of Humacyte, bought 10,000 shares of Humacyte common stock in an open-market purchase on 2026-09-14 at $0.56 per share, for a total reported value of $5,620. This was a purchase (transaction code P), which investors often view as a more informative signal than routine sales, though motivations are not disclosed.

Key Details

• Transaction date and price: 2026-09-14 — 10,000 shares @ $0.56 each.
• Total value: $5,620.
• Filing date: Form 4 filed 2026-09-15 (timely filing based on the reported dates).
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes/plan mentions: No 10b5-1 plan, tax withholding, option exercise, or other footnotes noted in the supplied transaction data.

Context The purchase is small in dollar terms, so while it represents an insider buying company stock, the modest size may limit how strongly it signals insider conviction. As always, this is a factual disclosure of trading activity—not a statement of intent or prediction about company performance.